申请人:BRUCE Ian
公开号:US20110105535A1
公开(公告)日:2011-05-05
Compounds of formula I
in free or salt form, wherein R
1
, R
2
, R
3
and R
4
have the meanings as indicated in the specification, are useful for treating conditions that are mediated by phosphatidylinositol 3-kinase.
Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
式I的化合物,无论是自由形式还是盐形式,其中R1、R2、R3和R4的含义如说明书所示,可用于治疗由磷脂酰肌醇3-激酶介导的疾病。还描述了含有这些化合物的制药组合物以及制备这些化合物的过程。